期刊文献+

人成骨肉瘤细胞系SOSP-9607的建立及其生物学特性的观察 被引量:6

Establishment and biological characters of a human osteosarcoma cell line SOSP-9607
原文传递
导出
摘要 目的 建立人成骨肉瘤细胞系。方法 采用原代组织块培养法对成骨肉瘤手术标本进行培养 ,对存活细胞进行形态学观察、组织化学染色、乳酸脱氢酶 (LDH)同工酶谱、细胞周期检查、核型分析、异种移植。结果 建立细胞系SOSP 96 0 7,其形态学表现、组织化学染色、LDH同工酶谱等均符合成骨肉瘤的特征。经 1年体外培养 ,已连续传代 12 0次 ,细胞倍增时间 2 9.8h ,细胞周期测定G1期为 48.2 %、G2 期为 2 0 .9%、S期为 30 .9%。染色体具有亚三倍体核型 ,众数为 6 4~ 6 6条。异种移植成瘤率 10 0 % ,无支原体污染。结论 人成骨肉瘤细胞系SOSP 96 0 7可用于对成骨肉瘤的研究。 Objective\ To establish a human osteosarcoma cell line. Methods\ The specimens which were identified as osteosarcoma were cultured primarily in vitro. The surviving cells underwent morphological observation, histochemical staining, isoenzyme pedigree (LDH) determination, cell cycling analysis, karyotype analysis and heterotransplantation. Results\ The newly established cell line SOSP 9607 was maintained in continuous culture for over 120 transfer generations in 1 year. Morphological observation, histochemical staining and LDH isoenzyme pedigree revealed that SOSP 9607 had the common features of osteosarcoma. The cell cycle analysis showed:G1 48.2%, G2 20.9%, S 30.9%. The doubling time of cells was about 29.8 h. The chromosome analysis showed a hypotriplaid feature with a model number of around 64~66. The cells remained free off mycoplasma and the tumor formation ratio of heterotransplantion was 100%. Conclusion\ The SOSP 9607 appeared to be a cell line derived from human osteosarcoma cells and could be used as a model for further study on osteosarcoma.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2000年第2期120-121,共2页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金!( 3 93 3 0 2 0 0 )
关键词 细胞系 成骨肉瘤 SOSP-9607 染色体核型 Sarcoma, osteogenic \ Cell line \ Karyotyping
  • 相关文献

参考文献3

二级参考文献4

共引文献17

同被引文献59

  • 1陈翔,杨彤涛,马保安,范清宇.不同转移潜能骨肉瘤细胞株的筛选与建立[J].华南国防医学杂志,2005,19(1):30-32. 被引量:1
  • 2裘秀春,单乐群,许彦鸣,杨彤涛,张殿忠,文艳华,刘云燕,杨连甲,杨安钢,范清宇.骨肉瘤HER2基因表达增加肺转移发生危险度[J].实用医学杂志,2006,22(2):123-124. 被引量:5
  • 3裘秀春,单乐群,许彦鸣,马保安,周勇,龙华,李钊,杨连甲,范清宇.HER2基因表达与骨肉瘤预后[J].现代肿瘤医学,2006,14(6):742-744. 被引量:3
  • 4段国庆,李书忠.凋亡抑制蛋白Survivin在骨肉瘤中的表达及其与PTEN、cyclinD1蛋白表达的关系[J].中国矫形外科杂志,2007,15(3):217-219. 被引量:5
  • 5Sanehez G, Delattre O, Auboeuf D, et al. Coupled alteration of transcription and splicing by a single oncogene: boosting the effect on cyclin D1 activity[J]. Cell Cycle, 2008, 7(15) : 2299 -2305.
  • 6Sanchez G, Bittencourt D, Laud K, et al. Alteration of cychn D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic Dlb splice isoform in cancer[J]. Proc Natl Acad Sci USA, 2008, 105(16) : 6004 -6009.
  • 7Chen BX, Erlanger BF. Cell cycle inhibition by an anti-cyclin D1 antibodychemically modified for intracellular deliver)[J]. Cancer Lett, 2006, 244(1): 71 -75.
  • 8Hitomi M, Stacey DW. Cellular ras and cyclin D1 are required during different cell cycle periods in cycling NIH 3T3 cells[ J]. Mol Cell Biol, 1999, 19(7) : 4623 -4632.
  • 9Xu F, Zhang X, Lei Y, et al. Loss of repression of HuR translation by miR-16 may be responsible for the elevation of HuR in human breast carcinoma. Journal of Cellular Biochemistry [J], 2010, 111 (3):727-34.
  • 10Bhattacharya R, Nicoloso M, Arvizo R, et al. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer [J]. Cancer Research, 2009, 69(23):9090-5.

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部